We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer.
- Authors
Aragon-Ching, Jeanny B; Jain, Lokesh; Gulley, James L; Arlen, Philip M; Wright, John J; Steinberg, Seth M; Draper, David; Venitz, Jürgen; Jones, Elizabeth; Chen, Clara C; Figg, William D; Dahut, William L
- Abstract
To determine if sorafenib is associated with an improved 4-month probability of progression-free survival, using radiographic and clinical criteria alone, in patients with metastatic castration-resistant prostate cancer. Secondary endpoints included pharmacokinetics, toxicity analysis and overall survival.
- Publication
BJU international, 2009, Vol 103, Issue 12, p1636
- ISSN
1464-410X
- Publication type
Journal Article
- DOI
10.1111/j.1464-410X.2008.08327.x